Are you Dr. Barth?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 39 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
550 Warwick Ave
Teaneck, NJ 07666Phone+1 201-421-5783- Is this information wrong?
Summary
- Dr. Jay Barth, MD is a pediatric gastroenterologist in Teaneck, New Jersey. He is currently licensed to practice medicine in New Jersey and New York.
Education & Training
Tufts Medical CenterFellowship, Pediatric Gastroenterology, 1993 - 1996
New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 1989 - 1993
Perelman School of Medicine at the University of PennsylvaniaClass of 1989
Certifications & Licensure
NJ State Medical License 1996 - 2025
NY State Medical License 1991 - 2025
Clinical Trials
- PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer Start of enrollment: 2007 Nov 01
- PTC299 for Treatment of Neurofibromatosis Type 2 Start of enrollment: 2009 Jul 31
- Study of Ataluren (PTC124) in Hemophilia A and B Start of enrollment: 2009 Oct 14
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsSafety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study.Derralynn Hughes, Kathleen Nicholls, Gere Sunder-Plassmann, Ana Jovanovic, Ulla Feldt-Rasmussen, Raphael Schiffmann, Roberto Giugliani, Vipul Jain, Christopher Viereck...> ;American Journal of Medical Genetics. Part A. 2019 Jun 1
- 63 citationsEfficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from...Dominique P. Germain, Kathy Nicholls, Roberto Giugliani, Daniel G. Bichet, Derralynn Hughes, Laura Barisoni, Robert B. Colvin, J. Charles Jennette, Nina Skuban, Jeffre...> ;Genetics in Medicine. 2019 Feb 6
- 5 citationsLow frequency of Fabry disease in patients with common heart disease.Raphael Schiffmann, Caren Swift, Nathan McNeill, Elfrida R. Benjamin, Jeffrey P. Castelli, Jay A. Barth, Lawrence Sweetman, Xuan Wang, Xiaoyang Wu> ;Genetics in Medicine. 2018 Jul 1
- Join now to see all
Press Mentions
- Digging into the Early Childhood Component of the Little Rock Tax PlanMay 4th, 2021
Lexeo Therapeutics Emerges with $85M, 18 Gene Therapy Programs and a Star-Studded TeamJanuary 7th, 2021
LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies for Rare and Non-Rare Monogenic DiseasesJanuary 7th, 2021- Join now to see all
